<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe a method for diagnosing <z:hpo ids='HP_0100775'>dural ectasia</z:hpo> (DE) and spinal canal widening (SCW) using CT </plain></SENT>
<SENT sid="1" pm="."><plain>We examined 23 patients with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan's syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>), 17 with <z:e sem="disease" ids="C0013720" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Ehlers-Danlos syndrome</z:e> (EDS) and 29 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects, using six axial slices at the level of the L1-S1 pedicles </plain></SENT>
<SENT sid="2" pm="."><plain>Transverse diameters of the vertebral bodies, spinal canal and dural sac were measured and indices were defined to differentiate patients with DE and SCW from <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>Statistical significance was assessed using Student's t -test, chi (2)-test and Pearson's correlation coefficient </plain></SENT>
<SENT sid="4" pm="."><plain>DE and SCW occurred in 69.6 % and 60.9 % of cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and in 23.5 % and 35.3 % of EDS respectively </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, prevalence was significantly higher than in the control group </plain></SENT>
<SENT sid="6" pm="."><plain>DE was significantly more frequent in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> than in EDS </plain></SENT>
<SENT sid="7" pm="."><plain>A strong correlation existed between DE and SCW in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> and the control group, but not in EDS </plain></SENT>
<SENT sid="8" pm="."><plain>Our system enables quantitative assessment of SCW and DE </plain></SENT>
<SENT sid="9" pm="."><plain>The latter is particularly important in subjects suspected of having <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, in whom it is a common and characteristic sign </plain></SENT>
</text></document>